Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.50% | 4.53% | 0.00% | -0.60% | -78.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.50% | 4.53% | 0.00% | -0.60% | -78.66% |
| Cost of Revenue | -52.75% | 36.45% | 1.04% | -2.31% | -93.25% |
| Gross Profit | 29.41% | -39.87% | -1.51% | 1.98% | -61.87% |
| SG&A Expenses | 17.06% | 17.54% | -3.19% | -6.29% | -37.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -363.51% | -89.74% | 22.36% | -96.39% | -- |
| Total Operating Expenses | -6.34% | 26.31% | -0.10% | -7.23% | -71.68% |
| Operating Income | 117.63% | -157.76% | 1.18% | 11,275.61% | -142.47% |
| Income Before Tax | 26.59% | 207.26% | 214.77% | 180.87% | -66.84% |
| Income Tax Expenses | -18.56% | 955.46% | 538.70% | 100.31% | 635.10% |
| Earnings from Continuing Operations | 108.82% | 187.57% | 200.00% | 201.82% | -88.70% |
| Earnings from Discontinued Operations | 543.72% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 418.29% | 187.57% | 200.00% | 201.82% | -60.82% |
| EBIT | 117.63% | -157.76% | 1.18% | 11,275.61% | -142.47% |
| EBITDA | 262.65% | -88.72% | 2.30% | 121.35% | -111.76% |
| EPS Basic | 187.00% | 200.00% | 200.00% | 209.09% | -45.75% |
| Normalized Basic EPS | -30.07% | 138.15% | 214.88% | 186.72% | -- |
| EPS Diluted | 187.00% | 200.00% | 200.00% | 209.09% | -45.75% |
| Normalized Diluted EPS | -30.07% | 138.15% | 214.88% | 186.72% | -- |
| Average Basic Shares Outstanding | 80.67% | -12.43% | 0.00% | -6.66% | -27.76% |
| Average Diluted Shares Outstanding | 80.67% | -12.43% | 0.00% | -6.66% | -27.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |